Bayer’s deal to buy Monsanto may face scrutiny back home in Germany

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Bayer faces a backlash against Germany’s biggest planned acquisition because of two products from the St. Louis-based company that are widely detested in the country: genetically modified seeds and the weedkiller Roundup…

“Germans view Monsanto as the main example of American corporate evil,” said Heike Moldenhauer, a biotechnology expert at German environmental group BUND. “It may not be such a good idea to take over Monsanto as that means incorporating its bad reputation, which would also make Bayer more vulnerable.”

A German Environment Ministry study released last month found 75 percent of citizens are against genetic engineering…

Related article:  Despite anti-GMO claims, herbicide use is not rising


Several German hardware store chains… stopped selling products using glyphosate last year in the wake of a report from the World Health Organization’s International Agency for Research on Cancer…


Bayer’s plan “is a wrong signal for Germany and environmental protection,” [Renate Kuenast, Germany’s former agriculture minister] said in an e-mail. “Monsanto stands for glyphosate and agricultural bio-engineering and thus for a loss of biodiversity and good soils. It’s a folly we need to stop.”

Read full, original post: Bayer’s mega Monsanto deal faces mega backlash in Germany

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend